Genes associated with inflammation, such as TNF-α, IL-6, and IFN-γ, may show increased expression in BECs of COVID-19-infected AD patients, indicating that SARS-CoV-2-induced immune responses could accelerate vascular breakdown, further contributing to cognitive decline in AD. Here, TNF is linked to Alzheimer disease.